Navigant was engaged by a medium sized pharmaceutical company to develop a product LOE (loss of exclusivity) roadmap to guide the brand strategy and tactics and provide the best opportunity for achieving the brand goals. The brand was a key financial asset for the client that operated in a highly genericized market with very little product differentiation. The Navigant team developed a comprehensive LOE overview and developed a strategic plan for the brand by engaging and focusing a large cross-functional client team on future considerations that was previously “off their RADAR”.